| General Information of Drug Metabolite (DM) (ID: DM018298) |
| DM Name |
Mipomersen Metabolite M1
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Endonuclease (ENDO)
|
DMEN805
|
| Unclear - Unclear |
Mipomersen
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Exonuclease 1 (EXO1)
|
DMEN806
|
| Unclear - Unclear |
Mipomersen
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Mipomersen |
DR5037
|
Approved |
Hypertriglyceridaemia |
|
|
| References |
| 1 |
Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
